Last reviewed · How we verify

NCT03420950: DO-RSI

Drug Order for Rapid Sequence Intubation

Completed NA Last updated 3 February 2022
What this trial tests

NA trial testing Rapid sequence intubation: sedative first in Acute Respiratory Failure in 335 participants. Completed in 29 September 2021.

Timeline
5 February 2018
Primary endpoint
29 September 2021
29 September 2021

Quick facts

Lead sponsorHennepin Healthcare Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment335
Start date5 February 2018
Primary completion29 September 2021
Estimated completion29 September 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hennepin Healthcare Research Institute

Who can join

18 and older, any sex, with Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, blinded trial comparing the order of drug administration for rapid sequence intubation in the Emergency Department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Respiratory Failure

Currently open trials in the same condition.

Other Hennepin Healthcare Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03420950.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing